Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Gialafos, A. Rapti, G. Siasos, A. Kalianos, M. Zaromitidou, P. Tsirovassilis, N. Maniakos, E. Oikonomou, E. Peros, F. Katsaros, K. Vlasis, L. Velentza, G. Mpirmpa, E. Taktikou, C. Stefanadis (Athens, Greece). Reduced heart rate variability is associated with increased level of serum ICAM-1 in patients with sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 769

Member's Comments

No comment yet.

Related content which might interest you: Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Abnormal heart rate variability in patients with sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Increased TNFα production in whole blood is associated with disease severity in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 497s Year: 2002 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Elevated plasma fibrinogen associated with reduced pulmonary function Source: Eur Respir J 2001; 18: Suppl. 33, 505s Year: 2001 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Elevated pulmonary vascular resistance is associated with increased risk of death in IPF Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Leptin levels are associated with reduced lung function in men with COPD Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Increased blood lead and cadmium levels in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 413s Year: 2001 The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease. Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Inflammation-sensitive plasma proteins are associated with increased incidence of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 629s Year: 2007